5-Bromosalicylic acid → 5-Bromo-N-(3,5-dinitrophenyl)-2-hydroxybenzamide

HRID 421139

반응식

HRID 421139 반응식
[Br:1][C:2]1[CH:10]=[C:6]([C:7]([OH:9])=O)[C:5]([OH:11])=[CH:4][CH:3]=1.[N+:12]([C:15]1[CH:16]=[C:17]([CH:19]=[C:20]([N+:22]([O-:24])=[O:23])[CH:21]=1)[NH2:18])([O-:14])=[O:13]>>[Br:1][C:2]1[CH:3]=[CH:4][C:5]([OH:11])=[C:6]([CH:10]=1)[C:7]([NH:18][C:17]1[CH:16]=[C:15]([N+:12]([O-:14])=[O:13])[CH:21]=[C:20]([N+:22]([O-:24])=[O:23])[CH:19]=1)=[O:9]

참가 물질

3

반응물 2

HCID 69725-Bromosalicylic acidHCID 120683,5-Dinitroaniline

생성물 1

HCID 178602425-Bromo-N-(3,5-dinitrophenyl)-2-hydroxybenzamide수율 32.2%

실험 절차

Using 5-bromosalicylic acid and 3,5-dinitroaniline as the raw materials, the same operation as the example 16 gave the title compound.

출처 및 근거

ORD 기록
ord-47e9469b06014b77a768a810307c561b
출처 데이터셋
uspto-grants-2012_01
특허 번호
US08097759B2

연결된 노트

불러오는 중…